Spelling suggestions: "subject:"enzymes."" "subject:"anzymes.""
291 |
The discriminator domain : does it reside at the C-terminus or the N-terminus of Escherichia coli Lon?Miller, Darcey L. 27 August 2001 (has links)
The mechanisms of substrate recognition by regulatory proteases are not well
understood. Presently, two opposing models have arisen to describe E. coil Lon's ability
to discriminate between substrates: one suggests the N-terminus involvement while the
second suggests the C-terminus involvement. In this project, the role of the C-terminal
domain as it relates to the recognition of Lon's normal physiological substrates RcsA, an
activator of colanic acid capsular polysaccharide, and SulA, an inhibitor of cell division,
was addressed. Using site-directed mutagenesis, five mutations in Lon (R537G, E538A,
GS40W, R542G, R542P) were isolated. Their phenotypic impact was either similar in
character to wildtype Lon (R537G, E538A) or ��lon cells (G540W, R542G, R542P). The
stabilization of both RcsA and SulA based on phenotypic assays and immunological
detection of lon* strains (G540W, R542G, R542P) suggests the C-terminal domain may
be involved in substrate degradation as opposed to discriminator activity. / Graduation date: 2002
|
292 |
Developmental and dietary regulation of flavin-containing monooxygenaseSu, Shelley A. Larsen 08 May 1998 (has links)
Graduation date: 1998
|
293 |
Kinetics of synthesis and degradation of chicken liver xanthine dehydrogenase /Epstein, Arnold. January 1971 (has links)
Thesis (Ph. D.)--Oregon State University, 1971. / Typescript (photocopy). Includes bibliographical references. Also available online.
|
294 |
Isolation, characterization, and expression analysis of genes encoding starch synthesizing enzymes from grain amaranthLu, Bei. January 2006 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2006. / Title proper from title frame. Also available in printed format.
|
295 |
Studies in biological surface science: microfluidics, photopatterning and artificial bilayersHolden, Matthew Alexander 30 September 2004 (has links)
Herein is presented the collective experimental record of research performed in the Laboratory for Biological Surface Science. These investigations are generally classified under the category of bioanalytical surface science and include the following projects. Chapters III and IV describe the creation of a microfluidic device capable of generating fixed arrays of concentration gradients. Experimental results were matched with computational fluid dynamics simulations to predict analyte distributions in these systems. Chapters V and VI demonstrate the discovery and utility of photobleaching fluorophores for micropatterning applications. Bleached fluorophores were found to rapidly attach to electron rich surfaces and this property was used to pattern enzymes inside microfluidic channels in situ. Finally, Chapter VII exhibits a method by which solid supported lipid bilayers can be dried and preserved by specifically bound proteins. The intrinsic property of lateral lipid mobility was maintained during this process and a mechanism by which the protein protects the bilayer was suggested.
|
296 |
Isolation and characterisation of esterases from thermophilic ActinomycesOldale, Megan January 2010 (has links)
<p>Alternative sources of fuel are required worldwide, and bio-ethanol is the leading candidate. Lignocellulosic biomass, a waste component of the agricultural industry, is a promising renewable source. Due to its complex structure it is highly recalcitrant, requiring the synergistic action of a battery of enzymes to achieve complete digestion. These enzymes include cellulases, hemicellulase and the accessory enzymes acetyl xylan esterase (AXE) and ferulic acid esterase (FAE). Thermpohilic Actinomyces isolates with the ability to hydrolyze xylan were screened for esterase activity. Two isolates (ORS10 and GSIV1), identified as Streptomyces spp, were positive for AXE activity. A cosmid library representative of isolate ORS10 was composed and screened for AXE activity using -naphthyl acetate as substrate. An 18 kb cosmid clone, 18D7, tested positive for AXE activity. Intracellular fractions extracted from ORS10 were precipitated with ammonium sulphate and partially purified 161-fold. Specific activity was measured after dialysis and ion-exchange chromatography. Overall yield of the partially purified enzyme was 34 %. Two protein bands of molecular masses 40 kDa and 60 kDa have been subjected to trypsin digestion and MALDI-TOF mass spectrometry analysis. The partially purified AXE displayed optimum activity at pH 9 and at 50° / C. AXE activity was stable for at least 1.5 hours between 30° / C and 40° / C, and for 24 hours between pH 6-9. The kM and Vmax values were 16.93 mg/ml and 1645 units/mg enzyme, respectively. The stability of the partially purified AXE at 30° / C-40° / C suggests potential for industrial applications that utilise mesophilic fermentations.</p>
|
297 |
Gene expression of xenobiotic metabolising enzymes in rat liver and kidney: differential effects of rooibos and honeybush herbal teasAbrahams, Sameega January 2011 (has links)
<p><!--[if gte mso 9]><xml>
<o:OfficeDocumentSettings>
<o:AllowPNG />
</o:OfficeDocumentSettings>
</xml><![endif]--></p>
<p><!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves />
<w:TrackFormatting />
<w:PunctuationKerning />
<w:ValidateAgainstSchemas />
<w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
<w:IgnoreMixedContent>false</w:IgnoreMixedContent>
<w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
<w:DoNotPromoteQF />
<w:LidThemeOther>EN-ZA</w:LidThemeOther>
<w:LidThemeAsian>X-NONE</w:LidThemeAsian>
<w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
<w:Compatibility>
<w:BreakWrappedTables />
<w:SnapToGridInCell />
<w:WrapTextWithPunct />
<w:UseAsianBreakRules />
<w:DontGrowAutofit />
<w:SplitPgBreakAndParaMark />
<w:EnableOpenTypeKerning />
<w:DontFlipMirrorIndents />
<w:OverrideTableStyleHps />
</w:Compatibility>
<m:mathPr>
<m:mathFont m:val="Cambria Math" />
<m:brkBin m:val="before" />
<m:brkBinSub m:val="- / -" />
<m:smallFrac m:val="off" />
<m:dispDef />
<m:lMargin m:val="0" />
<m:rMargin m:val="0" />
<m:defJc m:val="centerGroup" />
<m:wrapIndent m:val="1440" />
<m:intLim m:val="subSup" />
<m:naryLim m:val="undOvr" />
</m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
<w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267">
<w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal" />
<w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1" />
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2" />
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3" />
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4" />
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5" />
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6" />
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7" />
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8" />
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9" />
<w:LsdException Locked="false" Priority="39" Name="toc 1" />
<w:LsdException Locked="false" Priority="39" Name="toc 2" />
<w:LsdException Locked="false" Priority="39" Name="toc 3" />
<w:LsdException Locked="false" Priority="39" Name="toc 4" />
<w:LsdException Locked="false" Priority="39" Name="toc 5" />
<w:LsdException Locked="false" Priority="39" Name="toc 6" />
<w:LsdException Locked="false" Priority="39" Name="toc 7" />
<w:LsdException Locked="false" Priority="39" Name="toc 8" />
<w:LsdException Locked="false" Priority="39" Name="toc 9" />
<w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption" />
<w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title" />
<w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font" />
<w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle" />
<w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong" />
<w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis" />
<w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid" />
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text" />
<w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing" />
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading" />
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List" />
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid" />
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1" />
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2" />
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1" />
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2" />
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1" />
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2" />
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3" />
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List" />
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading" />
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List" />
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid" />
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1" />
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1" />
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1" />
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1" />
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1" />
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1" />
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision" />
<w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph" />
<w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote" />
<w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote" />
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1" />
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1" />
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1" />
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1" />
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1" />
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1" />
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1" />
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1" />
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2" />
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2" />
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2" />
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2" />
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2" />
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2" />
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2" />
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2" />
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2" />
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2" />
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2" />
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2" />
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2" />
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2" />
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3" />
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3" />
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3" />
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3" />
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3" />
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3" />
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3" />
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3" />
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3" />
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3" />
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3" />
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3" />
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3" />
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3" />
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4" />
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4" />
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4" />
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4" />
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4" />
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4" />
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4" />
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4" />
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4" />
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4" />
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4" />
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4" />
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4" />
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4" />
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5" />
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5" />
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5" />
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5" />
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5" />
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5" />
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5" />
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5" />
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5" />
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5" />
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5" />
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5" />
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5" />
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5" />
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6" />
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6" />
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6" />
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6" />
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6" />
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6" />
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6" />
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6" />
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6" />
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6" />
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6" />
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6" />
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6" />
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6" />
<w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis" />
<w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis" />
<w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference" />
<w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference" />
<w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title" />
<w:LsdException Locked="false" Priority="37" Name="Bibliography" />
<w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading" />
</w:LatentStyles>
</xml><![endif]--><!--[if gte mso 10]>
<style>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal" / mso-tstyle-rowband-size:0 / mso-tstyle-colband-size:0 / mso-style-noshow:yes / mso-style-priority:99 / mso-style-parent:"" / mso-padding-alt:0cm 5.4pt 0cm 5.4pt / mso-para-margin-top:0cm / mso-para-margin-right:0cm / mso-para-margin-bottom:10.0pt / mso-para-margin-left:0cm / line-height:115% / mso-pagination:widow-orphan / font-size:11.0pt / font-family:"Calibri","sans-serif" / mso-ascii-font-family:Calibri / mso-ascii-theme-font:minor-latin / mso-hansi-font-family:Calibri / mso-hansi-theme-font:minor-latin / mso-bidi-font-family:"Times New Roman" / mso-bidi-theme-font:minor-bidi / mso-fareast-language:EN-US / }
</style>
<![endif]--></p>
<p style="margin-bottom:0cm / margin-bottom:.0001pt / line-height:
normal / mso-layout-grid-align:none / text-autospace:none" class="MsoNormal"><span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">Laboratory studies, epidemiological investigations and human clinical trials indicate</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">that flavonoids have important effects on cancer chemoprevention and therapy.</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">Flavonoids may interfere in several steps that lead to cancer development but may</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">also lead to toxicity as the inhibition of carcinogen-activating enzymes may also cause</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">potential toxic flavonoid-drug interactions. However, the potential toxicity of these</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">dietary components has not been well studied. The use of polyphenol-enriched</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">supplements prepared from South African herbal teas, rooibos (</span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:
Helvetica-Oblique">Aspalathus linearis</span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">)</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">and honeybush (</span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:Helvetica-Oblique">Cyclopia </span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:
Helvetica">spp.) are being marketed to alleviate symptoms that are</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">known to be &ldquo / cured&rdquo / by the herbal teas. However, there is a lack of information</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">regarding the possible health promoting effects of these polyphenol-enriched extracts</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">on xenobiotic metabolism. In the present study, the modulating effects of aspalathinenriched</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">rooibos and mangiferin-enriched C. </span><i><span style="font-size:11.5pt / font-family:
Helvetica-Oblique / mso-bidi-font-family:Helvetica-Oblique">genistoides </span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:
Helvetica">and </span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:Helvetica-Oblique">C. subternata </span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:
Helvetica">extracts on</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">the gene expression of xenobiotic metabolising enzymes (XMEs) were investigated </span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:
Helvetica-Oblique">in</span></i> <i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:
Helvetica-Oblique">vivo </span></i><span style="font-size:11.5pt / font-family:
" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">in the rat liver and kidneys. An </span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:Helvetica-Oblique">in vitro </span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:
Helvetica">study, utilising a primary rat hepatocyte cell</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">model, was included to further evaluate changes in the expression of selected XMEs</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">by the herbal tea extracts, including their major polyphenolic constituents, aspalathin</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">and mangiferin. The use of the </span><i><span style="font-size:11.5pt / font-family:
Helvetica-Oblique / mso-bidi-font-family:Helvetica-Oblique">in vitro </span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:
Helvetica">primary hepatocytes assay as a predictive cell</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">model for the modulation of the expression of XMEs genes by the herbal tea extracts</span> <i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:
Helvetica-Oblique">in vivo </span></i><span style="font-size:11.5pt / font-family:
" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">was critically evaluated.</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">In the liver and kidneys, the </span><i><span style="font-size:11.5pt / font-family:
Helvetica-Oblique / mso-bidi-font-family:Helvetica-Oblique">C. subternata </span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:
Helvetica">polyphenol-enriched herbal tea extract</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">effected the majority of changes regarding the expression of XMEs genes when</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">compared to the rooibos and </span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:Helvetica-Oblique">C. genistoides</span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:
Helvetica">. Variations in the modulation of gene</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">expression of the XMEs by the herbal tea extracts were related to differences in their</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">polyphenol constituents, although non-polyphenolic constituent could also be involved.</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">Overall the herbal teas regulated alcohol, energy, drug and steroid metabolism in the</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">liver, whereas in the kidneys the gene expression of phase I, phase II, steroid</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">metabolising enzymes, as well as drug transporters were modulated. It would appear</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">that the herbal teas are likely to exhibit both beneficial and adverse effects </span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:
Helvetica-Oblique">in vivo</span></i><span style="font-size:11.5pt / font-family:
" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">, depending on the specific organ, the xenobiotic and/or drug that are involved. The</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">primary rat hepatocytes model display varying effects with respect to modulating gene</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">expression of specific XMEs by the polyphenol-enriched herbal tea extracts. Apart</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">from the reduction in 17<span style="font-size:
11.5pt / font-family:TT61t00 / mso-bidi-font-family:TT61t00">&beta / </span>-hydroxysteroid dehydrogenase gene expression care should</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">be taken to directly extrapolate the </span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:Helvetica-Oblique">in vitro </span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:
Helvetica">findings to changes that prevail </span><i><span style="font-size:
11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:Helvetica-Oblique">in vivo</span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">.</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">However, interesting results regarding the masking effect of complex mixture on the</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">modulation of XME gene expression of individual polyphenols were encountered. In</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">addition differences in the dose and duration of exposure between the </span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:
Helvetica-Oblique">in vitro </span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">and </span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:
Helvetica-Oblique">in</span></i> <i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:
Helvetica-Oblique">vivo </span></i><span style="font-size:11.5pt / font-family:
" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">studies were not comparable and should be further explored to validate the </span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:
Helvetica-Oblique">in vitro</span></i> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">primary hepatocytes model to predict changes </span><i><span style="font-size:11.5pt / font-family:Helvetica-Oblique / mso-bidi-font-family:Helvetica-Oblique">in vivo</span></i><span style="font-size:11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:
Helvetica">. Future studies should</span> <span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica">investigate the effects of the herbal tea extracts, its polyphenols and etabolites on</span><span style="font-size:
11.5pt / font-family:" / Helvetica" / ," / sans-serif" / mso-bidi-font-family:Helvetica"> ME induction at a protein level as well as varying herb-drug-enzyme interactions.</span></p>
<p>  / </p>
|
298 |
Structural and functional dissection of the vaccinia virus thymidine kinase enzymeBlack, Margaret E. 30 April 1991 (has links)
Thymidine kinase is a key enzyme in the nucleotide salvage pathway,
catalyzing the production of dTMP from thymidine and ATP. In order to
identify the structural features of the TK protein and/or primary amino
acid sequences which contribute to the catalytic and regulatory activities of
this enzyme, an in vitro transcription and translation system has been used
in concert with protein engineering techniques for the production and
phenotypic characterization of mutant and wild-type TK enzymes. Because
of discrepancies in the literature regarding the quaternary structure of the
VVTK, the native molecular weight and quaternary structure was
determined to be an 80kDa homotetrameric enzyme by glycerol gradient
fractionation, gel filtration and glutaraldehyde cross-linking analyses.
Computer-assisted alignment of the predicted amino acid sequences
derived from cellular and poxvirus TK genes identified seven highly-conserved
domains distributed throughout the VVTK polypeptide
(domains I-VII). Domain I (amino acid residues 11-18 ) exhibits a high
degree of similarity to both ATP and GTP binding site consensus sequences,
although the VVTK utilizes only ATP as a phosphate donor. Site directed
mutagenesis and ATP-agarose affinity chromatography techniques were
employed to confirm that this region was responsible for ATP binding and
to determine which amino acids were essential for efficient binding.
The TK gene (tdk) from E. coli was isolated and sequenced to serve as
a prokaryotic enzyme with which to compare VVTK. The alignment
revealed only 23% shared identity with VVTK and, interestingly, the
identical and similar residues were clustered into three of the seven
domains identified previously (domains I, III and VII).
Preliminary evidence supports domain III (residues 78-90) as a
putative magnesium binding site and that a highly conserved cysteine
residue (cysteine 170) within domain VII (residues 168-171) may be a
component of the catalytic site. Secondary structure alignment between
Herpes Simplex Virus (HSV) TK and monkeypox TK (a close relative of
VVTK) revealed that the putative nucleoside binding site of HSVTK aligns
with residues within domain IV. Replacement of a VVTK residue (Q114)
with the corresponding residue of HSVTK (an aspartic acid) greatly alters
the substrate specificity and dTTP sensitivity of VVTK. / Graduation date: 1991
|
299 |
Enzymatic dimerazation of substituted phenols.Schneider, Robert L. 01 January 1961 (has links)
No description available.
|
300 |
Enzymatic hydrolysis of cellulose.Walseth, Curtis Sanborn 06 1900 (has links)
No description available.
|
Page generated in 0.0247 seconds